DONNA KULAS: Open Payments
NPI 1184736969 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 22 payments from 8 companies in 2025. Trend: 2023 $21 · 2024 $189 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $141 |
| UCB, Inc. | 2 | $80 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Botanix SB Inc | 2 | $36 |
| LEO Pharma Inc. | 1 | $29 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $26 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
Products named: SKYRIZI, Bimzelx, SOFDRA, ANZUPGO, IDACIO, ILUMYA, COSENTYX.
Industry payments across MA — which companies pay providers there.
